Results 211 to 220 of about 74,948 (336)
FOXO1 mediates miR-99a-5p/E2F7 to restrain breast cancer cell proliferation and induce apoptosis
Background FOXO1 is known to act as a tumor suppressor gene in breast cancer, but its exact mechanism of action remains unclear. Objective This study aimed to clarify how FOXO1 suppresses breast cancer cell proliferation and induces apoptosis.
Ying Zhang +3 more
doaj +1 more source
Genetic inactivation of the phosphatase activity of soluble epoxide hydrolase prevents the development of pulmonary hypertension in rats, partly through upregulation of SIRT3 expression and decreased cell proliferation and apoptosis‐related proteins. Targeting sEH‐P emerges as a promising therapeutic strategy for pulmonary hypertension.
Matthieu Leuillier +17 more
wiley +1 more source
Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro [PDF]
Baolin Chen +7 more
openalex +1 more source
Epitranscriptomics as a Candidate Universal Modulator of Dormancy Transitions
Dormancy is presented as a conserved, reversible survival program in which epitranscriptomic RNA modifications are proposed to provide a rapid, energy‐efficient layer that establishes, maintains, and terminates the state by modulating mRNA stability, translation, and localization.
Ehsan Pashay Ahi
wiley +1 more source
The transcription factor Forkhead box protein O1 (FoxO1) is a well-established regulator of glucose and lipid metabolism, yet its role in metabolic dysfunction-associated steatohepatitis (MASH) pathogenesis remains debated.
Hui-Ting Chen +7 more
doaj +1 more source
Process Systems Engineering in Precision Medicine: Opportunities in Autologous CAR‐T Therapy
ABSTRACT Autologous chimeric antigen receptor (CAR)‐T therapies have given hope to many cancer patients whose other lines of treatment have failed. Unfortunately, limited manufacturing capability has resulted in many patients dying while on a waitlist.
B. Wayne Bequette
wiley +1 more source

